Infectious agents with biological weapon potential have become the focus of intense interest since the terrorist events of September 11, 2001 and the subsequent anthrax attacks. One area of proposed focus is to meld the experience of human immunologists with category A pathogen biologists to understand in detail the primary immune targets of potential pathogenic targets of bioterrorism. This proposal seeks to understand the humoral immune response to Bacillis anthracis through a collaborative project of human immunologists and an anthrax biologist. Over the past 15 years, the PI's laboratory has focused on defining the sequential antigenic B cell determinants of various autoimmune responses (1-24). Interestingly, we have also proven that this method of B cell epitope mapping works well for characterization of the immune response to pathogenic organisms (25-29 and unpublished observations). By understanding the fine specificity of these responses we have been able to define the initial epitope of specific lupus response, to determine and test association with potential environmental triggers of these responses and to induce lupus-like disease by animal immunization schemes. We now propose to utilize our extensive expertise in protein chemistry, fine specificity mapping, epitope confirmation, molecular modeling and animal immunization to identify the common B cell antigenic targets of Bacillus anthracis. Dr. Farris' experience with murine cellular immunology, including multiple antigenic peptide immunization (30) and dendritic cell biology (Preliminary Studies) will contribute to our evaluation of the identified epitopes for potential prophylactic and treatment value. In addition, this project will utilize the anthrax-specific reagents and experience of our co-investigator, Dr. Jimmy Ballard. We will use our modified solid phase peptide approach to build over 2700 maximally overlapping octapeptides and screen exposed individual and animal sera for common sequential epitopes. These antigenic regions will be confirmed by a separate fluid phase ELISA and the total percent of the immune response to the parent antigen comprised of detected anti-peptide reactivity will be determined. These novel antigenic epitopes will be screened for their ability to induce (1) neutralizing and spore germination inhibiting antibodies, (2) restoration of B. anthracis subverted phagocyte function and (3) protection in animals challenged with live spores.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI062629-05
Application #
7690707
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2008-09-01
Budget End
2009-08-31
Support Year
5
Fiscal Year
2008
Total Cost
$367,913
Indirect Cost
Name
Oklahoma Medical Research Foundation
Department
Type
DUNS #
077333797
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
More, Sunil; Yang, Xiaoyun; Zhu, Zhengyu et al. (2018) Regulation of influenza virus replication by Wnt/?-catenin signaling. PLoS One 13:e0191010
Hu, Zihua; Jiang, Kaiyu; Frank, Mark Barton et al. (2018) Modeling Transcriptional Rewiring in Neutrophils Through the Course of Treated Juvenile Idiopathic Arthritis. Sci Rep 8:7805
Booth, J Leland; Duggan, Elizabeth S; Patel, Vineet I et al. (2018) Gene expression profiling of primary human type I alveolar epithelial cells exposed to Bacillus anthracis spores reveals induction of neutrophil and monocyte chemokines. Microb Pathog 121:9-21
Seshadri, Sudarshan; Pope, Rosemary L; Zenewicz, Lauren A (2018) Glucocorticoids Inhibit Group 3 Innate Lymphocyte IL-22 Production. J Immunol 201:1267-1274
Girton, Alanson W; Popescu, Narcis I; Keshari, Ravi S et al. (2018) Serum Amyloid P and IgG Exhibit Differential Capabilities in the Activation of the Innate Immune System in Response to Bacillus anthracis Peptidoglycan. Infect Immun 86:
Langer, Marybeth; Girton, Alanson W; Popescu, Narcis I et al. (2018) Neither Lys- and DAP-type peptidoglycans stimulate mouse or human innate immune cells via Toll-like receptor 2. PLoS One 13:e0193207
DeVette, Christa I; Andreatta, Massimo; Bardet, Wilfried et al. (2018) NetH2pan: A Computational Tool to Guide MHC Peptide Prediction on Murine Tumors. Cancer Immunol Res 6:636-644
Popescu, Narcis I; Silasi, Robert; Keshari, Ravi S et al. (2018) Peptidoglycan induces disseminated intravascular coagulation in baboons through activation of both coagulation pathways. Blood 132:849-860
Fuentes-Mattei, Enrique; Giza, Dana Elena; Shimizu, Masayoshi et al. (2017) Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections. EBioMedicine 20:182-192
Dumas, Eric K; Garman, Lori; Cuthbertson, Hannah et al. (2017) Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated. Vaccine 35:3416-3422

Showing the most recent 10 out of 121 publications